Amicus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	634.21	528.3	399.36	329.23	305.51
Revenue Growth (YoY)	20.05%	32.29%	21.30%	7.76%	17.11%
Cost of Revenue	72.93	52.94	37.33	38.6	34.47
Gross Profit	561.28	475.35	362.03	290.63	271.05
Selling, General & Admin	383.49	323.38	275.27	213.04	192.71
Research & Development	135.84	109.36	152.38	276.68	272.05
Operating Expenses	526.79	441.29	435.52	495.06	470.97
Operating Income	34.49	34.06	-73.49	-204.43	-199.92
Interest Expense	-46.16	-49.6	-50.15	-37.12	-32.47
Interest & Investment Income	3.32	5.41	7.08	3.02	0.51
Other Non Operating Income (Expenses)	10.24	-9.44	-15.89	4.18	-2.9
EBT Excluding Unusual Items	1.89	-19.57	-132.45	-234.35	-234.78
Merger & Restructuring Charges	-	-9.19	-	-	-
Asset Writedown	-1.7	-	-1.13	-6.62	-
Other Unusual Items	-	-	-16.52	-1.08	-6.77
Pretax Income	0.19	-28.76	-150.1	-242.04	-241.55
Income Tax Expense	27.3	27.35	1.48	-5.47	8.91
Net Income	-27.11	-56.11	-151.58	-236.57	-250.46
Net Income to Common	-27.11	-56.11	-151.58	-236.57	-250.46
Shares Outstanding (Basic)	308	304	295	289	271
Shares Outstanding (Diluted)	308	304	295	289	271
Shares Change (YoY)	1.31%	3.12%	2.11%	6.50%	4.85%
EPS (Basic)	-0.09	-0.18	-0.51	-0.82	-0.92
EPS (Diluted)	-0.09	-0.18	-0.51	-0.82	-0.92
Free Cash Flow	29.85	-37.44	-76.53	-170.34	-206.38
Free Cash Flow Per Share	0.10	-0.12	-0.26	-0.59	-0.76
Gross Margin	88.50%	89.98%	90.65%	88.28%	88.72%
Operating Margin	5.44%	6.45%	-18.40%	-62.09%	-65.44%
Profit Margin	-4.28%	-10.62%	-37.96%	-71.85%	-81.98%
Free Cash Flow Margin	4.71%	-7.09%	-19.16%	-51.74%	-67.55%
EBITDA	41.95	42.61	-65.62	-199.08	-193.71
EBITDA Margin	6.62%	8.07%	-16.43%	-60.47%	-63.41%
D&A For EBITDA	7.46	8.55	7.87	5.34	6.21
EBIT	34.49	34.06	-73.49	-204.43	-199.92
EBIT Margin	5.44%	6.45%	-18.40%	-62.09%	-65.44%
Effective Tax Rate	14293.72%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.